Dr Reddys Laboratories Ltd Share Price Today - Live Blog for April 09, 2026

Dr Reddys Laboratories Ltd witnessed a substantial 1.62% increase in its share price and is currently trading at 1210.70. This remarkable performance has caught the eye of investors.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 1.73% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1212.00 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 1.73%, with its current market value per share resting at 1212.00. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price rallied by 1.56%, reaching the current market price of 1210.00. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd's share price rallied by 1.56%, reaching the current market price of 1210.00. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd witnessed a notable 1.69% surge in its share price and is presently trading at 1211.50, captivating the attention of market participants.

Demonstrating a commendable 1.69% gain, Dr Reddys Laboratories Ltd's share price is currently situated at 1211.50. In terms of valuation, the stock maintains a PE ratio of 18.0100, while the industry PE ratio stands at 31.5108.

Dr Reddys Laboratories Ltd's shares saw an increase of 1.10%, reaching the current market price of 1204.50. This development underscores the stock's growing popularity.

After a notable 1.10% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1204.50. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 1.10%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of 1204.50 per share.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 1.10% gain, with the share price now at 1204.50. Notably, the stock's PE ratio stands at 18.0100, and its Return on Equity (ROE) is 16.0277.